Skip to main content

Amylyx Pharmaceuticals, Inc.

AMLX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001658551

In the last 90 days, Amylyx Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 6 sales; 206 institutions reported holding it in 13F filings for Q2 2026, worth $2.07B in total; no superinvestor holds it.

13F holders, Q1 2025

Institutional positions in Amylyx Pharmaceuticals, Inc. as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
136
+16 vs. Q4 2024
Shares held
73.9M
+24.1M (+48.4%) vs. Q4 2024
Total value
$261.6M
+$73.3M (+39.0%) vs. Q4 2024
New holders
32
50 more added
Sold out
16
31 more reduced

2 institutions that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q4 2024: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting AMLX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ1 2025: 136 institutions
Q1 2021: 0 institutionsQ2 2021: 0 institutionsQ3 2021: 0 institutionsQ4 2021: 0 institutionsQ1 2022: 72 institutionsQ2 2022: 78 institutionsQ3 2022: 95 institutionsQ4 2022: 133 institutionsQ1 2023: 147 institutionsQ2 2023: 154 institutionsQ3 2023: 170 institutionsQ4 2023: 178 institutionsQ1 2024: 143 institutionsQ2 2024: 119 institutionsQ3 2024: 110 institutionsQ4 2024: 122 institutionsQ1 2025: 136 institutionsQ2 2025: 131 institutionsQ3 2025: 169 institutionsQ4 2025: 180 institutionsQ1 2026: 171 institutionsQ2 2026: 206 institutions
Value heldQ1 2025: $261.6M
Q1 2021: $0Q2 2021: $0Q3 2021: $0Q4 2021: $0Q1 2022: $299.9MQ2 2022: $512.9MQ3 2022: $1.05BQ4 2022: $1.79BQ1 2023: $1.51BQ2 2023: $1.18BQ3 2023: $1.08BQ4 2023: $887.4MQ1 2024: $141.5MQ2 2024: $82.9MQ3 2024: $140.8MQ4 2024: $188.3MQ1 2025: $261.6MQ2 2025: $523.6MQ3 2025: $1.49BQ4 2025: $1.36BQ1 2026: $1.59BQ2 2026: $2.07B
Institutions holding AMLX and their total value by quarter
QuarterHoldersValue
Q2 2026206$2.07B
Q1 2026171$1.59B
Q4 2025180$1.36B
Q3 2025169$1.49B
Q2 2025131$523.6M
Q1 2025136$261.6M
Q4 2024122$188.3M
Q3 2024110$140.8M
Q2 2024119$82.9M
Q1 2024143$141.5M
Q4 2023178$887.4M
Q3 2023170$1.08B
Q2 2023154$1.18B
Q1 2023147$1.51B
Q4 2022133$1.79B
Q3 202295$1.05B
Q2 202278$512.9M
Q1 202272$299.9M
Q4 20210$0
Q3 20210$0
Q2 20210$0
Q1 20210$0

Institutions, Q1 2025

Shares, value and share of portfolio for each institution holding Amylyx Pharmaceuticals, Inc.; share changes are against Q4 2024.

Institutions holding AMLX in Q1 2025
InstitutionSharesValue% of portfolioChange in sharesAction
Rock Springs Capital Management LP343,228$1.22M0.07%+343,228New
OrbiMed Advisors LLC348,000$1.23M0.03%00.0%Unchanged
Charles Schwab Investment Management Inc372,853$1.32M0.00%+73,904+24.7%Added
Citigroup Inc463,240$1.64M0.00%−146,084−24.0%Reduced
Morgan Stanley474,418$1.68M0.00%+10,198+2.2%Added
Renaissance Technologies LLC515,100$1.82M0.00%+50,700+10.9%Added
Deutsche Bank AG570,857$2.02M0.00%00.0%Unchanged
Two Sigma Advisers, LP649,800$2.30M0.01%+408,400+169.2%Added
Alyeska Investment Group, L.P.750,412$2.66M0.01%−73,008−8.9%Reduced
Two Sigma Investments, LP762,053$2.70M0.01%+110,536+17.0%Added
Bank of America Corp794,354$2.81M0.00%−1,631,909−67.3%Reduced
Geode Capital Management, LLC806,161$2.85M0.00%+238,258+42.0%Added
PFM Health Sciences, LP834,135$2.95M0.23%+834,135New
Point72 Asset Management, L.P.916,966$3.25M0.01%+916,966New
Qube Research & Technologies Ltd942,891$3.34M0.01%+162,325+20.8%Added
FMR LLC1,157,988$4.10M0.00%+426,632+58.3%Added
Connor, Clark & Lunn Investment Management Ltd.1,199,691$4.25M0.02%−63,662−5.0%Reduced
UBS Group AG1,388,427$4.92M0.00%+744,903+115.8%Added
Susquehanna International Group, LLP1,470,925$5.21M0.01%+602,543+69.4%Added
ADAR1 Capital Management, LLC1,471,587$5.21M1.00%+1,471,587New
Woodline Partners LP1,609,447$5.70M0.04%+1,609,447New
Boxer Capital Management, LLC1,750,000$6.20M1.86%00.0%Unchanged
Great Point Partners LLC1,811,996$6.41M3.49%+1,811,996New
Goldman Sachs Group Inc2,002,961$7.09M0.00%+143,065+7.7%Added
Almitas Capital LLC2,122,597$7.51M2.49%+90,227+4.4%Added
BlackRock, Inc.2,387,409$8.45M0.00%+108,475+4.8%Added
683 Capital Management, LLC2,411,400$8.54M0.87%+481,400+24.9%Added
Saturn V Capital Management LLC2,426,436$8.59M4.33%+1,537,363+172.9%Added
Standard Life Aberdeen plc2,430,358$8.60M0.02%+707,553+41.1%Added
Citadel Advisors LLC2,757,776$9.76M0.01%+787,072+39.9%Added
Nantahala Capital Management, LLC2,934,405$10.4M0.86%+1,482,252+102.1%Added
Millennium Management LLC3,081,853$10.9M0.01%+2,487,617+418.6%Added
Vanguard Group Inc4,116,512$14.6M0.00%+1,424,023+52.9%Added
Adage Capital Partners GP, L.L.C.5,697,605$20.2M0.04%+5,697,605New
TCG Crossover Management, LLC5,943,812$21.0M2.87%+1,300,000+28.0%Added
Perceptive Advisors LLC7,874,348$27.9M0.99%+1,100,000+16.2%Added
Ikarian Capital, LLC0$00.00%−201,187−100.0%Sold out
AQR Capital Management LLC0$00.00%−188,386−100.0%Sold out
Mackenzie Financial Corp0$00.00%−111,310−100.0%Sold out
Jump Financial, LLC0$00.00%−104,342−100.0%Sold out
Boothbay Fund Management, LLC0$00.00%−80,543−100.0%Sold out
Landscape Capital Management, L.L.C.0$00.00%−49,661−100.0%Sold out
Wedbush Securities Inc0$00.00%−19,914−100.0%Sold out
Y-Intercept (Hong Kong) Ltd0$00.00%−14,809−100.0%Sold out
Rpo LLC0$00.00%−12,136−100.0%Sold out
Alpine Global Management, LLC0$00.00%−12,017−100.0%Sold out
Bank of Nova Scotia0$00.00%−11,884−100.0%Sold out
Fox Run Management, L.L.C.0$00.00%−11,788−100.0%Sold out
Vident Advisory, LLC0$00.00%−10,862−100.0%Sold out
Walleye Trading LLC0$00.00%−2,649−100.0%Sold out
SRS Capital Advisors, Inc.0$00.00%−2,193−100.0%Sold out
Advisor Group Holdings, Inc.0$00.00%−638−100.0%Sold out
Oliver Lagore Vanvalin Investment Group––––Not filed
Global Retirement Partners, LLC––––Not filed